Madison Stoddard

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Respiratory Syndrome Coronavirus

Advanced Non Small Cell Lung Cancer

Toll Like Receptor

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine Albright, Debra Van Egeren, Aditya Thakur, Arijit Chakravarty, Laura F White, Madison Stoddard
Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion. PloS one 18 (10) (2023)
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Shruthi Mangalaganesh, Ryan P Nolan, Dean Bottino, Greg Hather, Natasha S Hochberg, Laura F White, Arijit Chakravarty
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy. Vaccines 11 (4) (2023)
Debra Van Egeren, Madison Stoddard, Laura F White, Natasha S Hochberg, Michael S Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines 11 (4) (2023)
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Shruthi Mangalaganesh, Ryan P Nolan, Dean Bottino, Greg Hather, Natasha S Hochberg, Laura F White, Arijit Chakravarty
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy. Vaccines 11 (4) (2023)
Debra Van Egeren, Madison Stoddard, Laura F White, Natasha S Hochberg, Michael S Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines 11 (4) (2023)
Debra Van Egeren, Madison Stoddard, Laura F White, Natasha S Hochberg, Michael S Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines 11 (4) (2023)
Debra Van Egeren, Madison Stoddard, Laura F White, Natasha S Hochberg, Michael S Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines 11 (4) (2023)
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Shruthi Mangalaganesh, Ryan P Nolan, Dean Bottino, Greg Hather, Natasha S Hochberg, Laura F White, Arijit Chakravarty
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy. Vaccines 11 (4) (2023)
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Shruthi Mangalaganesh, Ryan P Nolan, Dean Bottino, Greg Hather, Natasha S Hochberg, Laura F White, Arijit Chakravarty
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy. Vaccines 11 (4) (2023)
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael Rogers, Bradley L Pentelute, Jonathan M Carlson, Mark Hixon, Diane Joseph-McCarthy, Arijit Chakravarty
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. PloS one 16 (4) (2021)
Debra Van Egeren, Madison Stoddard, Alexander Novokhodko, Michael S Rogers, Diane Joseph-McCarthy, Bruce Zetter, Arijit Chakravarty
Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis. PloS one 16 (11) (2021)
Madison Stoddard, Sharanya Sarkar, Lin Yuan, Ryan P Nolan, Douglas E White, Laura F White, Natasha S Hochberg, Arijit Chakravarty
Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2. PloS one 16 (7) (2021)